MedTrace Logo

A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

NCT04126668 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-05-21

No results posted yet for this study

Summary

The main objective of this study is to evaluate the Effect of Food on the Pharmacokinetics of CM082 tablet.

Conditions

  • Advanced Malignant Solid Tumors

Interventions

DRUG

CM082 with fed or fasting

The two groups of subjects were given an equal dose of CM082 tablet (200 mg) after a single cross-over fasting or high-fat high-calorie diet in two different test cycles to examine the effect of food on the pharmacokinetics of CM082.

Sponsors & Collaborators

  • AnewPharma

    lead INDUSTRY

Principal Investigators

  • zourong ruan · the Second Affiliated Hospital of Zhejiang University Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-19
Primary Completion
2020-01-16
Completion
2020-01-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04126668 on ClinicalTrials.gov